Ventilation support in SARS-CoV-2 pneumonia. Strategy and indication

Rev Esp Quimioter. 2022 Apr;35 Suppl 1(Suppl 1):50-53. doi: 10.37201/req/s01.12.2022. Epub 2022 Apr 22.

Abstract

The SARS-CoV2 pandemic has generated a need for knowledge, new concepts in pathophysiology and an increase of the use of respiratory support in highly complex patients. This fact has provoked the need to evolve to the concept of personalized ventilatory support according to the patient's response to treatment.

Publication types

  • Review

MeSH terms

  • COVID-19*
  • Humans
  • Pneumonia*
  • RNA, Viral
  • SARS-CoV-2

Substances

  • RNA, Viral